NASDAQ : BDTX
-$0.02 (-1.1%)
19
0
-$
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Behbahani Ali | director | 2026-06-26 | A-Award | 1.71 | 2026-06-29 |
| Kulkarni Samarth | director | 2026-06-26 | A-Award | 1.71 | 2026-06-29 |
| Menzel Garry E | director | 2026-06-26 | A-Award | 1.71 | 2026-06-29 |
| Raman Prakash | director | 2026-06-26 | A-Award | 1.71 | 2026-06-29 |
| Dhingra Kapil | director | 2026-06-26 | A-Award | 1.71 | 2026-06-29 |
| Campbell Shannon | director | 2026-06-26 | A-Award | 1.71 | 2026-06-29 |
| Behbahani Ali | director | 2026-06-19 | A-Award | 1.66 | 2026-06-22 |
| Raman Prakash | director | 2026-06-19 | A-Award | 1.66 | 2026-06-22 |
| Behbahani Ali | director | 2026-03-20 | A-Award | 2.15 | 2026-03-20 |
| Raman Prakash | director | 2026-03-20 | A-Award | 2.15 | 2026-03-20 |
| Jones Erika | officer: SEE REMARKS | 2026-01-21 | A-Award | 2.57 | 2026-01-23 |
| Hatzis-Schoch Brent | officer: SEE REMARKS | 2026-01-21 | A-Award | 2.57 | 2026-01-23 |
| Buck Elizabeth | officer: CHIEF SCIENTIFIC OFFICER | 2026-01-21 | A-Award | 2.57 | 2026-01-23 |
| Yurasov Sergey | officer: CHIEF MEDICAL OFFICER | 2026-01-21 | A-Award | 2.57 | 2026-01-23 |
| Velleca Mark A. | director, officer: PRESIDENT & CEO | 2026-01-21 | A-Award | 2.57 | 2026-01-23 |
| Behbahani Ali | director | 2025-12-12 | A-Award | 2.76 | 2025-12-15 |
| Raman Prakash | director | 2025-12-12 | A-Award | 2.76 | 2025-12-15 |
| Behbahani Ali | director | 2025-09-19 | A-Award | 3.35 | 2025-09-22 |
| Raman Prakash | director | 2025-09-19 | A-Award | 3.35 | 2025-09-22 |
| Behbahani Ali | director | 2025-06-20 | A-Award | 2.33 | 2025-06-20 |
| Raman Prakash | director | 2025-06-20 | A-Award | 2.33 | 2025-06-20 |
| Behbahani Ali | director | 2025-06-12 | A-Award | 2.43 | 2025-06-12 |
| Menzel Garry E | director | 2025-06-12 | A-Award | 2.43 | 2025-06-12 |
| Raman Prakash | director | 2025-06-12 | A-Award | 2.43 | 2025-06-12 |
| Campbell Shannon | director | 2025-06-12 | A-Award | 2.43 | 2025-06-12 |
| Dhingra Kapil | director | 2025-06-12 | A-Award | 2.43 | 2025-06-12 |
| Kulkarni Samarth | director | 2025-06-12 | A-Award | 2.43 | 2025-06-12 |
| Behbahani Ali | director | 2025-03-21 | A-Award | 1.88 | 2025-03-21 |
| Raman Prakash | director | 2025-03-21 | A-Award | 1.88 | 2025-03-21 |
| BIOTECH GROWTH N V | 10 percent owner | 2025-03-19 | S-Sale | 2.0691 | 2025-03-20 |
| BIOTECH GROWTH N V | 10 percent owner | 2025-03-19 | S-Sale | 1.943 | 2025-03-20 |
| BIOTECH GROWTH N V | 10 percent owner | 2025-03-19 | S-Sale | 2.3081 | 2025-03-20 |
| BIOTECH GROWTH N V | 10 percent owner | 2025-03-19 | S-Sale | 2.0004 | 2025-03-20 |
| BIOTECH GROWTH N V | 10 percent owner | 2025-03-19 | S-Sale | 2.0929 | 2025-03-20 |
| BIOTECH GROWTH N V | 10 percent owner | 2025-03-19 | S-Sale | 1.9532 | 2025-03-20 |
| BIOTECH GROWTH N V | 10 percent owner | 2025-03-19 | S-Sale | 2.1169 | 2025-03-20 |
| Velleca Mark A. | director, officer: PRESIDENT & CEO | 2025-01-30 | A-Award | 2.52 | 2025-01-31 |
| Velleca Mark A. | director, officer: PRESIDENT & CEO | 2025-01-30 | A-Award | 0 | 2025-01-31 |
| Yurasov Sergey | officer: CHIEF MEDICAL OFFICER | 2025-01-30 | A-Award | 2.52 | 2025-01-31 |
| Yurasov Sergey | officer: CHIEF MEDICAL OFFICER | 2025-01-30 | A-Award | 0 | 2025-01-31 |
| Buck Elizabeth | officer: CHIEF SCIENTIFIC OFFICER | 2025-01-30 | A-Award | 2.52 | 2025-01-31 |
| Buck Elizabeth | officer: CHIEF SCIENTIFIC OFFICER | 2025-01-30 | A-Award | 0 | 2025-01-31 |
| Jones Erika | officer: SEE REMARKS | 2025-01-30 | A-Award | 2.52 | 2025-01-31 |
| Jones Erika | officer: SEE REMARKS | 2025-01-30 | A-Award | 0 | 2025-01-31 |
| Hatzis-Schoch Brent | officer: SEE REMARKS | 2025-01-30 | A-Award | 2.52 | 2025-01-31 |
| Hatzis-Schoch Brent | officer: SEE REMARKS | 2025-01-30 | A-Award | 0 | 2025-01-31 |
| Behbahani Ali | director | 2024-12-13 | A-Award | 2.5 | 2024-12-16 |
| Raman Prakash | director | 2024-12-13 | A-Award | 2.5 | 2024-12-16 |
| Campbell Shannon | director | 2024-12-13 | A-Award | 2.5 | 2024-12-16 |
| Behbahani Ali | director | 2024-09-20 | A-Award | 4.78 | 2024-09-20 |
| Campbell Shannon | director | 2024-09-20 | A-Award | 4.78 | 2024-09-20 |
| Raman Prakash | director | 2024-09-20 | A-Award | 4.78 | 2024-09-20 |
| Versant Venture Capital VI, L.P. | 10 percent owner | 2024-08-28 | S-Sale | 6.3202 | 2024-08-30 |
| Behbahani Ali | director | 2024-06-21 | A-Award | 4.98 | 2024-06-21 |
| Raman Prakash | director | 2024-06-21 | A-Award | 4.98 | 2024-06-21 |
| Campbell Shannon | director | 2024-06-21 | A-Award | 4.98 | 2024-06-21 |
| Behbahani Ali | director | 2024-06-06 | A-Award | 4.65 | 2024-06-06 |
| Kulkarni Samarth | director | 2024-06-06 | A-Award | 4.65 | 2024-06-06 |
| Menzel Garry E | director | 2024-06-06 | A-Award | 4.65 | 2024-06-06 |
| Raman Prakash | director | 2024-06-06 | A-Award | 4.65 | 2024-06-06 |
| Campbell Shannon | director | 2024-06-06 | A-Award | 4.65 | 2024-06-06 |
| Dhingra Kapil | director | 2024-06-06 | A-Award | 4.65 | 2024-06-06 |
| Campbell Shannon | director | 2024-04-10 | A-Award | 4.98 | 2024-04-12 |
| Raman Prakash | director | 2024-04-10 | A-Award | 4.98 | 2024-04-12 |
| Campbell Shannon | 2024-04-10 | 0 | 2024-04-12 | ||
| Raman Prakash | 2024-04-10 | 0 | 2024-04-12 | ||
| Behbahani Ali | director | 2024-03-15 | A-Award | 4.54 | 2024-04-03 |
| DIXON WENDY L | director | 2024-03-15 | A-Award | 4.54 | 2024-04-03 |
| Ni Fang | officer: SEE REMARKS | 2024-02-14 | A-Award | 4.86 | 2024-02-15 |
| Hatzis-Schoch Brent | officer: SEE REMARKS | 2024-02-14 | A-Award | 4.86 | 2024-02-15 |
| Yurasov Sergey | officer: CHIEF MEDICAL OFFICER | 2024-02-14 | A-Award | 4.86 | 2024-02-15 |
| Buck Elizabeth | officer: CHIEF SCIENTIFIC OFFICER | 2024-02-14 | A-Award | 4.86 | 2024-02-15 |
| Velleca Mark A. | director, officer: PRESIDENT & CEO | 2024-02-14 | A-Award | 4.86 | 2024-02-15 |
| Jones Erika | officer: SEE REMARKS | 2024-02-14 | A-Award | 4.86 | 2024-02-15 |
| Behbahani Ali | director | 2023-12-15 | A-Award | 2.73 | 2023-12-15 |
| DIXON WENDY L | director | 2023-12-15 | A-Award | 2.73 | 2023-12-15 |
| BIOTECH GROWTH N V | 10 percent owner | 2023-10-17 | P-Purchase | 2.3352 | 2023-10-19 |
| Behbahani Ali | director | 2023-09-15 | A-Award | 3.6 | 2023-09-18 |
| Velleca Mark A. | director, officer: PRESIDENT & CEO | 2023-09-17 | A-Award | 3.55 | 2023-09-18 |
| Velleca Mark A. | director, officer: PRESIDENT & CEO | 2023-09-15 | A-Award | 3.6 | 2023-09-18 |
| DIXON WENDY L | director | 2023-09-15 | A-Award | 3.6 | 2023-09-18 |
| RA CAPITAL MANAGEMENT, L.P. | director | 2023-07-05 | P-Purchase | 5 | 2023-07-07 |
| Behbahani Ali | director | 2023-07-05 | P-Purchase | 5 | 2023-07-06 |
| BIOTECH GROWTH N V | 10 percent owner | 2023-06-30 | P-Purchase | 5 | 2023-07-03 |
| BIOTECH GROWTH N V | 10 percent owner | 2023-06-27 | P-Purchase | 5.4914 | 2023-06-29 |
| Epstein David M. | director, officer: SEE REMARKS | 2023-06-27 | S-Sale | 6.7 | 2023-06-28 |
| Behbahani Ali | director | 2023-06-16 | A-Award | 2.1 | 2023-06-16 |
| DIXON WENDY L | director | 2023-06-16 | A-Award | 2.1 | 2023-06-16 |
| Velleca Mark A. | director | 2023-06-16 | A-Award | 2.1 | 2023-06-16 |
| Behbahani Ali | director | 2023-05-16 | A-Award | 1.82 | 2023-05-17 |
| Mayweg Alexander | director | 2023-05-16 | A-Award | 1.82 | 2023-05-17 |
| Shah Rajeev M. | director | 2023-05-16 | A-Award | 1.82 | 2023-05-17 |
| Velleca Mark A. | director | 2023-05-16 | A-Award | 1.82 | 2023-05-17 |
| Menzel Garry E | director | 2023-05-16 | A-Award | 1.82 | 2023-05-17 |
| Kulkarni Samarth | director | 2023-05-16 | A-Award | 1.82 | 2023-05-17 |
| DIXON WENDY L | director | 2023-05-16 | A-Award | 1.82 | 2023-05-17 |
| Dhingra Kapil | director | 2023-05-16 | A-Award | 1.82 | 2023-05-17 |
| Behbahani Ali | director | 2023-03-16 | A-Award | 1.67 | 2023-03-20 |
| DIXON WENDY L | director | 2023-03-16 | A-Award | 1.67 | 2023-03-20 |
| Velleca Mark A. | director | 2023-03-16 | A-Award | 1.67 | 2023-03-20 |